Patients With Relapsed or Refractory (R/R) Nucleophosmin 1–Mutated (NPM1m) Acute Myeloid Leukemia (AML): Updated Results from the Phase 2 AUGMENT-101 Study

Poster Presentation | Jun 12, 2025

Author

Arellano ML, et al.

Congress

European Hematology Association Annual Congress 2025

Milan, Italy | June 12 – 15, 2025